312 related articles for article (PubMed ID: 16967195)
1. Toward automated biochemotype annotation for large compound libraries.
Chen X; Liang Y; Xu J
Mol Divers; 2006 Aug; 10(3):495-509. PubMed ID: 16967195
[TBL] [Abstract][Full Text] [Related]
2. Robustness of biological activity spectra predicting by computer program PASS for noncongeneric sets of chemical compounds.
Poroikov VV; Filimonov DA; Borodina YV; Lagunin AA; Kos A
J Chem Inf Comput Sci; 2000; 40(6):1349-55. PubMed ID: 11128093
[TBL] [Abstract][Full Text] [Related]
3. Leadlikeness and structural diversity of synthetic screening libraries.
Verheij HJ
Mol Divers; 2006 Aug; 10(3):377-88. PubMed ID: 17031539
[TBL] [Abstract][Full Text] [Related]
4. Discriminating between drugs and nondrugs by prediction of activity spectra for substances (PASS).
Anzali S; Barnickel G; Cezanne B; Krug M; Filimonov D; Poroikov V
J Med Chem; 2001 Jul; 44(15):2432-7. PubMed ID: 11448225
[TBL] [Abstract][Full Text] [Related]
5. Similarity searching and scaffold hopping in synthetically accessible combinatorial chemistry spaces.
Boehm M; Wu TY; Claussen H; Lemmen C
J Med Chem; 2008 Apr; 51(8):2468-80. PubMed ID: 18380426
[TBL] [Abstract][Full Text] [Related]
6. Drug discovery in the kinase inhibitory field using the Nested Chemical Library technology.
Kéri G; Székelyhidi Z; Bánhegyi P; Varga Z; Hegymegi-Barakonyi B; Szántai-Kis C; Hafenbradl D; Klebl B; Muller G; Ullrich A; Erös D; Horváth Z; Greff Z; Marosfalvi J; Pató J; Szabadkai I; Szilágyi I; Szegedi Z; Varga I; Wáczek F; Orfi L
Assay Drug Dev Technol; 2005 Oct; 3(5):543-51. PubMed ID: 16305311
[TBL] [Abstract][Full Text] [Related]
7. An ontology for pharmaceutical ligands and its application for in silico screening and library design.
Schuffenhauer A; Zimmermann J; Stoop R; van der Vyver JJ; Lecchini S; Jacoby E
J Chem Inf Comput Sci; 2002; 42(4):947-55. PubMed ID: 12132896
[TBL] [Abstract][Full Text] [Related]
8. Method for effective virtual screening and scaffold-hopping in chemical compounds.
Wale N; Karypis G; Watson IA
Comput Syst Bioinformatics Conf; 2007; 6():403-14. PubMed ID: 17951843
[TBL] [Abstract][Full Text] [Related]
9. Assessing the scaffold diversity of screening libraries.
Krier M; Bret G; Rognan D
J Chem Inf Model; 2006; 46(2):512-24. PubMed ID: 16562979
[TBL] [Abstract][Full Text] [Related]
10. Lessons learnt from assembling screening libraries for drug discovery for neglected diseases.
Brenk R; Schipani A; James D; Krasowski A; Gilbert IH; Frearson J; Wyatt PG
ChemMedChem; 2008 Mar; 3(3):435-44. PubMed ID: 18064617
[TBL] [Abstract][Full Text] [Related]
11. Design of small molecule libraries for NMR screening and other applications in drug discovery.
Jacoby E; Davies J; Blommers MJ
Curr Top Med Chem; 2003; 3(1):11-23. PubMed ID: 12570776
[TBL] [Abstract][Full Text] [Related]
12. Managing, profiling and analyzing a library of 2.6 million compounds gathered from 32 chemical providers.
Monge A; Arrault A; Marot C; Morin-Allory L
Mol Divers; 2006 Aug; 10(3):389-403. PubMed ID: 17031540
[TBL] [Abstract][Full Text] [Related]
13. From activity cliffs to activity ridges: informative data structures for SAR analysis.
Vogt M; Huang Y; Bajorath J
J Chem Inf Model; 2011 Aug; 51(8):1848-56. PubMed ID: 21761918
[TBL] [Abstract][Full Text] [Related]
14. "Bayes affinity fingerprints" improve retrieval rates in virtual screening and define orthogonal bioactivity space: when are multitarget drugs a feasible concept?
Bender A; Jenkins JL; Glick M; Deng Z; Nettles JH; Davies JW
J Chem Inf Model; 2006; 46(6):2445-56. PubMed ID: 17125186
[TBL] [Abstract][Full Text] [Related]
15. Rethinking molecular similarity: comparing compounds on the basis of biological activity.
Petrone PM; Simms B; Nigsch F; Lounkine E; Kutchukian P; Cornett A; Deng Z; Davies JW; Jenkins JL; Glick M
ACS Chem Biol; 2012 Aug; 7(8):1399-409. PubMed ID: 22594495
[TBL] [Abstract][Full Text] [Related]
16. Scaffold selection and scaffold hopping in lead generation: a medicinal chemistry perspective.
Zhao H
Drug Discov Today; 2007 Feb; 12(3-4):149-55. PubMed ID: 17275735
[TBL] [Abstract][Full Text] [Related]
17. Emerging chemical patterns: a new methodology for molecular classification and compound selection.
Auer J; Bajorath J
J Chem Inf Model; 2006; 46(6):2502-14. PubMed ID: 17125191
[TBL] [Abstract][Full Text] [Related]
18. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases.
Ghose AK; Viswanadhan VN; Wendoloski JJ
J Comb Chem; 1999 Jan; 1(1):55-68. PubMed ID: 10746014
[TBL] [Abstract][Full Text] [Related]
19. Molecular shape diversity of combinatorial libraries: a prerequisite for broad bioactivity.
Sauer WH; Schwarz MK
J Chem Inf Comput Sci; 2003; 43(3):987-1003. PubMed ID: 12767158
[TBL] [Abstract][Full Text] [Related]
20. Quest for the rings. In silico exploration of ring universe to identify novel bioactive heteroaromatic scaffolds.
Ertl P; Jelfs S; Mühlbacher J; Schuffenhauer A; Selzer P
J Med Chem; 2006 Jul; 49(15):4568-73. PubMed ID: 16854061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
